Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Human amyotrophic lateral sclerosis excitability phenotype screen: Target discovery and validation

Cell Reports(2021)10.1016/j.celrep.2021.109224Source: DataRank Database

Human amyotrophic lateral sclerosis excitability phenotype screen: Target discovery and validation is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 61 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access61 citations

Download PDF

Cite:

Linked data & code

geo nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: goldTopics (20)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Kasper C. D. Roet ORCID,Liying Zhang ORCID,Amy Brault,Allison P. Berg ORCID,Anne B. Jefferson

Live enrichment

PubMed:34107252 PMC:PMC8209673

National Institutes of Health

Grant: 1R35NS105076

National Institutes of Health

Grant: U54HD090255

NINDS NIH HHS

Grant: R35 NS105076

National Institutes of Health

Grant: 5R35NS105076-04

Unravelling mechanisms and novel therapeutic targets for peripheral neuropathy and neuropathic pain

National Institutes of Health

Grant: 5U54HD090255-05

Boston Intellectual and Developmental Disabilities Research Center

Boston Children's Hospital

University of California, Los Angeles

goldLicense: CC BY NC ND

publisherhttps://api.elsevier.com/content/article/PII:S2211124721005751?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124721005751?httpAccept=text/plain

Europe_PMChttps://europepmc.org/articles/PMC8209673

Europe_PMChttps://europepmc.org/articles/PMC8209673?pdf=render

https://doi.org/10.1016/j.celrep.2021.109224

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansAmyotrophic Lateral SclerosisCell DifferentiationPhenotype

Keywords

High throughputALSPhenotypic ScreenHyperexcitabilityKv7D2 ReceptorHigh ContentAmpa ToxicityPhenotypeAmyotrophic Lateral SclerosisHumansCell DifferentiationArticle

Sustainable Development Goals

SDG 3: 3. Good health

Human amyotrophic lateral sclerosis excitability phenotype screen: Target discovery and validation

FAIR Checklist

Authors (24)

Funding (7 grants)

Open Access

Topics

Annotations (Europe PMC)